Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
logo
mobile-logo
HomeInvestingFirst patient dosed in Phase IIb imaging for Brain Mets

First patient dosed in Phase IIb imaging for Brain Mets

0
0
4
Investing

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

related posts
Investing

(TheNewswire) Silver Crown Royalties Inc. (

Investing

The American economy may be heading toward

Investing

Nutritional Growth Solutions Limited (ASX:NGS) (‘NGS’ or

Investing

Q1 2025 Operational and Financial Highlights Gold equivalent

previous article
next article
No comments

Sorry, the comment form is closed at this time.

Disclaimer

Disclaimer: retirementinvestingadvice.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Top Stories
Copyright © 2025 retirementinvestingadvice.com | All Rights Reserved